Dow Jones

39 375,87

0,17%

DAX

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
GSK Plc (PK) (GLAXF)
GSK Plc (PK) (GLAXF) Actualités

GLAXF

GSK (PK) (GLAXF)

GSK Plc (PK)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:GLAXF

Date	Heure	Source	Titre	Symbole	Société
18/06/2024	22h20	Edgar (US Regulatory)	Form 11-K - Annual report of employee stock purchase, savings and similar plans	USOTC:GLAXF	GSK Plc (PK)
12/06/2024	17h19	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:GLAXF	GSK Plc (PK)
31/05/2024	22h21	Edgar (US Regulatory)	Form SD - Specialized disclosure report	USOTC:GLAXF	GSK Plc (PK)
09/02/2024	22h18	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	USOTC:GLAXF	GSK Plc (PK)
06/02/2024	23h10	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	USOTC:GLAXF	GSK Plc (PK)
27/06/2023	14h42	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	USOTC:GLAXF	GSK Plc (PK)
30/05/2023	20h33	Edgar (US Regulatory)	Specialized Disclosure Report (sd)	USOTC:GLAXF	GSK Plc (PK)
10/03/2023	18h21	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	USOTC:GLAXF	GSK Plc (PK)
10/03/2023	17h23	Edgar (US Regulatory)	Notice of Iran-related Disclosure Filed Pursuant to Section 13(r)(3) of the Exchange Act (irannotice)	USOTC:GLAXF	GSK Plc (PK)
10/03/2023	17h17	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	USOTC:GLAXF	GSK Plc (PK)
14/02/2023	19h55	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:GLAXF	GSK Plc (PK)
28/06/2022	16h38	Edgar (US Regulatory)	Annual Report of Employee Stock Plans (11-k)	USOTC:GLAXF	GSK Plc (PK)
17/05/2022	22h38	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:GLAXF	GSK Plc (PK)
09/05/2022	16h36	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	USOTC:GLAXF	GSK Plc (PK)
06/05/2022	22h43	Edgar (US Regulatory)	Securities Registration (ads, Immediate) (f-6ef)	USOTC:GLAXF	GSK Plc (PK)
14/02/2022	19h31	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	USOTC:GLAXF	GSK Plc (PK)
13/08/2021	13h07	Edgar (US Regulatory)	Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)	USOTC:GLAXF	GSK Plc (PK)
14/05/2021	14h36	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	USOTC:GLAXF	GSK Plc (PK)
26/03/2021	18h33	Edgar (US Regulatory)	Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (f-3asr)	USOTC:GLAXF	GSK Plc (PK)
15/03/2021	19h49	Edgar (US Regulatory)	Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)	USOTC:GLAXF	GSK Plc (PK)
07/10/2020	16h33	Edgar (US Regulatory)	Certification by the Exchange Approving Securities for Listing (cert)	USOTC:GLAXF	GSK Plc (PK)
01/10/2020	20h53	Edgar (US Regulatory)	Securities Registration (section 12(b)) (8-a12b)	USOTC:GLAXF	GSK Plc (PK)
01/10/2020	20h50	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	USOTC:GLAXF	GSK Plc (PK)
28/09/2020	22h26	Edgar (US Regulatory)	Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)	USOTC:GLAXF	GSK Plc (PK)
28/09/2020	15h31	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)	USOTC:GLAXF	GSK Plc (PK)
03/02/2020	17h32	Edgar (US Regulatory)	Amended Report of Foreign Issuer (6-k/a)	USOTC:GLAXF	GSK Plc (PK)
20/12/2019	22h47	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	USOTC:GLAXF	GSK Plc (PK)
06/05/2015	22h59	The Motley Fool	Why Sarepta Therapeutics, Inc. Shares Soared Today	USOTC:GLAXF	GSK Plc (PK)